WI

WT Investment Advisors Fund

North America, Wisconsin, United States, Oshkosh

Description

WT Investment Advisors Fund is a privately held American biotechnology companies.

Investor Profile

WT Investment Advisors Fund has backed more than 3 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Private Equity, Series E, Series D rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.

Stage Focus

  • Private Equity (33%)
  • Series E (33%)
  • Series D (33%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does WT Investment Advisors Fund frequently co-invest with?

Credit Suisse
North America, North Carolina, United States, Morrisville
Co-Investments: 1
TPG-Axon Capital
North America, New York, United States, New York
Co-Investments: 2
CV
North America, Utah, United States, Salt Lake City
Co-Investments: 1
Unilever Ventures
Europe, England, United Kingdom, London
Co-Investments: 1
Jennison Associates
North America, New York, United States, New York
Co-Investments: 2
SD
North America, Utah, United States, Salt Lake City
Co-Investments: 2

What are some of recent deals done by WT Investment Advisors Fund?

Merrimack

Cambridge, Massachusetts, United States

Merrimack is a biopharmaceutical company that designs and develops medicines to treat cancer.

BiotechnologyHealth CarePharmaceutical
Private EquityApr 14, 2011
Amount Raised: $77,000,000
Merrimack

Cambridge, Massachusetts, United States

Merrimack is a biopharmaceutical company that designs and develops medicines to treat cancer.

BiotechnologyHealth CarePharmaceutical
Series EApr 3, 2006
Amount Raised: $65,000,000
Merrimack

Cambridge, Massachusetts, United States

Merrimack is a biopharmaceutical company that designs and develops medicines to treat cancer.

BiotechnologyHealth CarePharmaceutical
Series DApr 20, 2005
Amount Raised: $28,300,000

Find More Investors Like WT Investment Advisors Fund

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

WT Investment Advisors Fund | Pipeseed